Clinical Trials Directory

Trials / Completed

CompletedNCT02794831

Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections

Status
Completed
Phase
Study type
Observational
Enrollment
335 (actual)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

* NSAIDs are widely consumed, and some are currently available for self-medication with indications 'Pain and Fever' (Cavalié, National Agency for Drug Safety (ANSM), 2014) * There is no recommendation to limit their use in bacterial infections except for chicken pox in children. * To date, no study has highlighted the aggravating role of exposure to NSAIDs on bacterial infections in adults, based on the usual septic severity Levy's score (SSS), and mortality, but it delays adequate antibiotics (Legras, Critical Care, 2009) * Community-acquired bacterial infections in adults exposed to NSAIDs are serious by their spread (multiple locations), and suppurative character requiring frequent use of invasive procedures such as surgery or drainage. The SSS does not reflect the seriousness of these infections. They are frequently associated with use of ibuprofen (63.4%), and self-medication practices (65.5%). The main hypothesis is that NSAIDs exposure is associated with a specific severity of community-acquired bacterial infection, marked by dissemination, suppurative complications or even invasive procedures requirement. Our objectives are also to: * Describe what NSAID use terms are associated to the risk of serious bacterial infections: molecule, dosage, duration of exposure, access (prescription or self-medication), associated drugs. * To determine what type (s) (s) of bacterial infection is worsened by exposure to NSAIDs. * To determine if other risk factors contribute to severity of bacterial community acquired infection * To describe hospital costs associated to such severity of bacterial infection

Conditions

Timeline

Start date
2016-09-22
Primary completion
2018-04-10
Completion
2018-04-10
First posted
2016-06-09
Last updated
2019-09-20

Source: ClinicalTrials.gov record NCT02794831. Inclusion in this directory is not an endorsement.